Amazon's $6 for a six-month supply of prescription drugs means investors in retail pharma must be extra-cautious right now

July 15, 2021 | Case Study

When Walmart started its $4 generic drug program, it had an overnight chilling effect on both pharmacy retail companies like CVS and Rite Aid and mom-and-pop pharmacies, which had to drastically slash their pricing to compete. This was possible largely because of the historically high margins on many of the drugs that were affected and the ability to draw consumers who were paying out of pocket due to either a lack of insurance or high prescription drug premiums. Despite the passing of the Affordable Care Act (ACA), many patients remain uninsured and struggle to pay for chronic care medications. Amazon is specifically targeting the same demographic, but with an update that reflects the current retail landscape: digital purchase and delivery.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978